Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.68 |
| ▸ | LPL | P06858 | 12/20 | 0.68 |
| ▸ | ESR1 | P03372 | 2/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.38 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.38 |
| ▸ | P4HB | P07237 | 1/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27026511 | 0.94 | LIPG (0.62) | LIPGLPLESR1ESR2GPR84 | |
| SCHEMBL24377031 | 0.92 | LIPG (0.79) | LIPGLPLESR1ESR2DGAT1 | |
| SCHEMBL10018882 | 0.92 | LIPG (0.79) | LIPGLPLESR1ESR2DGAT1 | |
| SCHEMBL24377051 | 0.92 | LIPG (0.79) | LIPGLPLESR1ESR2DGAT1 | |
| SCHEMBL29587465 | 0.92 | LIPG (0.79) | LIPGLPLESR1ESR2DGAT1 | |
| SCHEMBL24377088 | 0.92 | LIPG (0.79) | LIPGLPLESR1ESR2DGAT1 | |
| SCHEMBL25799121 | 0.91 | LIPG (0.77) | LIPGLPLESR1ESR2DGAT1 | |
| SCHEMBL31667850 | 0.91 | LIPG (0.77) | LIPGLPLESR1ESR2DGAT1 | |
| SCHEMBL15600476 | 0.90 | LIPG (0.71) | LIPGLPLDGAT1IRAK4PRMT5 | |
| SCHEMBL24377072 | 0.90 | LIPG (0.75) | LIPGLPLESR1ESR2DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240023427-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2024-01-18 | — | — | US | disclosed |
| US-20240023427-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240023427-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CCNL2, AHR, ARNT | LIPG 3077/4885LPL 2919/4885ESR1 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.